Difference between revisions of "Template:Lipid metabolism disorders"
Jump to navigation
Jump to search
imported>Was a bee m (→top: ICD code exported (from bot request)) |
|||
| (10 intermediate revisions by 9 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Lipid metabolism disorders |
| − | | title = [[Inborn error of metabolism|Inborn error]] of [[Inborn error of lipid metabolism|lipid metabolism]]: [[dyslipidemia]] | + | | title = [[Inborn error of metabolism|Inborn error]] of [[Inborn error of lipid metabolism|lipid metabolism]]: [[dyslipidemia]] |
| + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} | ||
| + | | listclass = hlist | ||
| − | | | + | | group1 = [[Hyperlipidemia]] |
| − | | | + | | list1 = |
| + | * [[Hypercholesterolemia]]/[[Hypertriglyceridemia]] | ||
| + | ** [[Lipoprotein lipase deficiency|Lipoprotein lipase deficiency/Type Ia]] | ||
| + | ** [[Familial apoprotein CII deficiency|Familial apoprotein CII deficiency/Type Ib]] | ||
| + | ** [[Familial hypercholesterolemia|Familial hypercholesterolemia/Type IIa]] | ||
| + | ** [[Combined hyperlipidemia|Combined hyperlipidemia/Type IIb]] | ||
| + | ** [[Familial dysbetalipoproteinemia|Familial dysbetalipoproteinemia/Type III]] | ||
| + | ** [[Familial hypertriglyceridemia|Familial hypertriglyceridemia/Type IV]] | ||
| + | * [[Xanthoma|Xanthoma/Xanthomatosis]] | ||
| − | | | + | | group2 = [[Hypolipoproteinemia]] |
| − | | | + | | list2 = {{Navbox|child |
| + | | evenodd = swap | ||
| − | | | + | | group1 = [[Hypoalphalipoproteinemia|Hypoalphalipoproteinemia/HDL]] |
| − | | | + | | list1 = |
| + | * [[Lecithin cholesterol acyltransferase deficiency]] | ||
| + | * [[Tangier disease]] | ||
| − | | | + | | group2 = [[Hypobetalipoproteinemia|Hypobetalipoproteinemia/LDL]] |
| − | | | + | | list2 = |
| + | * [[Abetalipoproteinemia]] | ||
| + | * [[Apolipoprotein B deficiency]] | ||
| + | * [[Chylomicron retention disease]] | ||
| − | + | }} | |
| − | |||
| − | + | <!-- group3 omitted to preserve alternating striping --> | |
| − | | | + | | group4 = [[Lipodystrophy]] |
| − | | | + | | list4 = |
| + | * [[Barraquer–Simons syndrome]] | ||
| − | | | + | | group5 = Other |
| − | | | + | | list5 = |
| + | * [[Lipomatosis]] | ||
| + | * [[Adiposis dolorosa]] | ||
| + | * [[Urbach–Wiethe disease|Lipoid proteinosis]] | ||
| + | * [[Familial renal amyloidosis|APOA1 familial renal amyloidosis]] | ||
| − | + | }}<noinclude> | |
| − | + | {{collapsible option}} | |
| − | + | [[Category:Metabolic disorder templates]] | |
| − | + | </noinclude> | |
Latest revision as of 21:28, 13 August 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Lipid metabolism disorders|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Lipid metabolism disorders|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Lipid metabolism disorders|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.